A mobility shift assay for DNA detection using nanochannel ...
Electro Mobility Shift Assay EMSA Band Shift Assay Gel Shift Assay R. Voll 09/01.
-
Upload
clemence-gray -
Category
Documents
-
view
220 -
download
3
Transcript of Electro Mobility Shift Assay EMSA Band Shift Assay Gel Shift Assay R. Voll 09/01.
Electro Mobility Shift Assay
EMSA
Band Shift Assay
Gel Shift Assay
R. Voll 09/01
R. Voll 09/01
Regulatory Region Coding Sequence
Gene Regulation by Transcription Factors
Application:
R. Voll 09/01
Detection of DNA-binding factors/proteins
•Analysis of DNA sequences (e. g. promoter or enhancer regions) for their potential to bind specifically to proteins/nuclear extracts
•Analysis of (sub-)cellular extracts for the presence of certain DNA-binding proteins (e. g. a transcription factor with a known recognition sequence)
EMSA: Principle
R. Voll 09/01
A double-stranded oligonucleotide containig a NF-B- binding site is labeled with a radioactive isotope and incubated with a nuclear extract.During gel-electrophoresis, NF-B bound to the oligonucleotide causes a shift compared to the free probe.
NF-B
Free Probe
Radioaktively labeled oligonucleotidewith NF-B - binding site (probe) and bound NF-B
Radioactively labeled oligonucleotide with NF-B - binding site (probe)
Nuclear extract of non-activated cells
Nuclear extract ofactivated cells
Preparation of Nuclear and Cytosolic Extracts
R. Voll 09/01
The procedure is carried out on ice rsp at 4°C and in the presence of protease (and phosphatase) inhibitors.
1. Swell cells in hypotonic lysis buffer 2. Add NP-40 and vortex to disrupt cytoplasmic membrane3. Centrifuge to pellet nuclei4. Carefully remove supernatant (contains cytosolic and membrane fraction)4. Wash nuclear pellet once in lysis buffer5. Add hypertonic extraction buffer to nuclear pellet6. Agitate vigouresly for 30 minutes7. Centrifuge at high speed8. Remove nuclear extract, determine protein concentration and freeze on dry ice until EMSA is performed
The Probe
R. Voll 09/01
Double stranded radiolabeled oligonucleotides containing a transcription factor binding site
AP-15’-GCT TGA TGA CTC AGC CGG AA C-3’3’-CGA ACT ACT GAG TCG GCC TT G-5’
NF-B5’-AGT TGA GGG GAC TTT CCC AGG C-3’3’-TCA ACT CCC CTC AAA GGG TCC G-5’
Binding motif
R. Voll 09/01
Annealing the Oligos
Heat up an equimolar mixture of the 2 oligos to 95°C and let them slowly cool down by turning off the heat block.
Labeling the Probe (I)
R. Voll 09/01
A. T4 Polynucleotide Kinase
5’-AGT TGA GGG GAC TTT CCC AGG-3’ 3’-CA ACT CCC CTC AAA GGG TCC G-5’
5’-P-AGT TGA GGG GAC TTT CCC AGG-3’ 3’-CA ACT CCC CTC AAA GGG TCC G-P-5’
PNK
+ Adenosin-P-P-P (-ATP)
Labeling the Probe (II)
R. Voll 09/01
B. Klenow Fragment of E. coli DNA Polymerase I
5’-ACT TGA GGG GAC TTT CCC AG-3’ 3’-A ACT CCC CTC AAA GGG TCC G-5’
5’-ACT TGA GGG GAC TTT CCC AGG C-3’3’-TGA ACT CCC CTC AAA GGG TCC G-5’
Klenow
+ -32-P dGTP + dCTP + dTTP
Removal of Unincorporated Nucleotides
R. Voll 09/01
Remove not incorporated nucleotides by Sephadex G50 column
or
non-denaturing PA gel purification
or
repeated ethanol precipitation
Reagents
R. Voll 09/01
Competitor DNA: Competition of unspecificpoly (dI-dC) . poly (dI-dC) binding (e. g. histones)
BSA: Protection of nuclear extracts
GTP: ?
Radiolabeled Probe: Detection of DNA-binding proteins
Reaction Buffer Binding conditions
Analysis by non-DenaturingPolyacrylamide Gel
Electrophoresis
R. Voll 09/01
Proof of Specificity
R. Voll 09/01
Supershift using antibodies against the DNA-binding protein
Competition for binding to the radiolabeled probe usingunlabeled wildtype and mutated oligos
R. Voll 09/01
Supershift
A double-stranded oligonucleotide containig a NF-B- binding site is labelled radioactive and incubated with a nuclear extract.During gel-electrophoresis, NF-B bound to the oligonucleotide causes a shift compared to the free probe.
p50/p65
Free probe
Radioaktiv labelled oligonucleotidewith NF-B - binding site (probe) and bound NF-B
Radioactiv labelled oligonucleotide with NF-B - binding site (probe)
Nuclear extract of activated cells
Nuclear extract of activated cells with anti-p50 antibody
p50/p65 + anti-p50
R. Voll 09/01
Competition with Unlabeled Oligos
Increasing amounts of unlabeled oligos containing the NF-B binding siteor unlabeled oligos with a mutated binding site were added to the reaction mixprior to gel electrophoresis. Specific binding is extinguished only by the non-mutated oligo.
p50/p50
Free probe
p50/p65
Unspecific
Wild type oligo Mutated oligo
GGG GAC TTT CCC GGA GAC TTT CCC